106 related articles for article (PubMed ID: 2662020)
1. [Erythromelalgia and thrombotic thrombocythemia].
Michiels JJ
Ned Tijdschr Geneeskd; 1989 May; 133(19):971-3. PubMed ID: 2662020
[No Abstract] [Full Text] [Related]
2. [Case of erythromelalgia due to essential thrombocythemia].
Usukine K; Shinhori H; Idetsuki T; Taoka K; Nakasone H; Kida M; Iki S; Urabe M; Oseto K; Igarashi A
Rinsho Ketsueki; 2007 May; 48(5):351-2. PubMed ID: 17571577
[No Abstract] [Full Text] [Related]
3. Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin.
van Genderen PJ; Michiels JJ; van Strik R; Lindemans J; van Vliet HH
Thromb Haemost; 1995 Feb; 73(2):210-4. PubMed ID: 7792731
[TBL] [Abstract][Full Text] [Related]
4. Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera.
van Genderen PJ; Michiels JJ
Semin Thromb Hemost; 1997; 23(4):357-63. PubMed ID: 9263352
[TBL] [Abstract][Full Text] [Related]
5. Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; van Vliet HH
Blood Cells Mol Dis; 2006; 36(2):199-205. PubMed ID: 16510297
[TBL] [Abstract][Full Text] [Related]
6. Erythromelalgia--a thrombotic complication in chronic myeloproliferative disorders.
Tarach JS; Nowicka-Tarach BM; Matuszek B; Nowakowski A
Med Sci Monit; 2000; 6(1):204-8. PubMed ID: 11208311
[TBL] [Abstract][Full Text] [Related]
7. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
[TBL] [Abstract][Full Text] [Related]
8. Erythromelalgia due to essential thrombocythemia.
McCarthy L; Eichelberger L; Skipworth E; Danielson C
Transfusion; 2002 Oct; 42(10):1245. PubMed ID: 12423504
[No Abstract] [Full Text] [Related]
9. Erythromelalgia versus erythermalgia.
Michiels JJ
Lancet; 1990 Jul; 336(8708):183-4. PubMed ID: 1973503
[No Abstract] [Full Text] [Related]
10. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.
Landolfi R; Di Gennaro L; Novarese L; Patrono C
Semin Thromb Hemost; 2006 Apr; 32(3):251-9. PubMed ID: 16673279
[TBL] [Abstract][Full Text] [Related]
11. [Histopathologic lesions in erythromelalgia during essential thrombocythemia].
Croue A; Gardembas-Pain M; Verret JL; Boasson M; Rousselet MC; Saint Andre JP
Ann Pathol; 1993; 13(2):128-30. PubMed ID: 8363673
[TBL] [Abstract][Full Text] [Related]
12. Erythromelalgia in patients with essential thrombocythemia and polycythemia vera.
Hou JL; Onajin O; Gangat N; Davis MD; Wolanskyj AP
Leuk Lymphoma; 2017 Mar; 58(3):715-717. PubMed ID: 27684959
[No Abstract] [Full Text] [Related]
13. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
Michiels JJ; Berneman Z; Schroyens W; van Urk H
Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947
[TBL] [Abstract][Full Text] [Related]
14. [Cutaneous manifestations of essential thrombocythemia. Erythromelalgia, ischemic acrocyanosis, livedo racemosa].
Bauerschmitz J; Knop J
Hautarzt; 1995 Jul; 46(7):477-80. PubMed ID: 7672987
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
16. [Abnormalities of platelet aggregation during essential thrombocythemia. Effect of aspirin on erythromelalgia].
Boneu B; Pris J; Guiraud B; Boneu A; Auvergnat A; Corberand J; Monnier J; Biermé R
Nouv Presse Med; 1972 Oct; 1(36):2383-8. PubMed ID: 5082818
[No Abstract] [Full Text] [Related]
17. Antiplatelet agents in the treatment of thrombotic complications of primary thrombocythemia.
Vera JC
Can Med Assoc J; 1979 Jan; 120(1):60-1. PubMed ID: 570087
[No Abstract] [Full Text] [Related]
18. Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation.
van Genderen PJ; Lucas IS; van Strik R; Vuzevski VD; Prins FJ; van Vliet HH; Michiels JJ
Thromb Haemost; 1996 Sep; 76(3):333-8. PubMed ID: 8883266
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and pathophysiology of erythromelalgia and erythermalgia.
Drenth JP; Michiels JJ
Am J Med; 1992 Jul; 93(1):111-4. PubMed ID: 1626563
[No Abstract] [Full Text] [Related]
20. Essential thrombocythemia and pregnancy: Observations from recent studies and management recommendations.
Tefferi A; Passamonti F
Am J Hematol; 2009 Oct; 84(10):629-30. PubMed ID: 19731306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
